Communications publiées lors de congrès ou colloques nationaux et internationaux (118)

  1. 45. Dekoninck, A., Calomme, C., De Launoit, Y., Burny, A., Ghysdael, J., & Van Lint, C. (2004). Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat. Abstract of the “HTLV European Research Network (HERN) (4-6 June, 2004: Halkidiki, Grèce)
  2. 46. Calomme, C., Dekoninck, A., Nguyen, T. L.-A., Willems, L., Kettmann, R., Burny, A., & Van Lint, C. (2004). Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5’ long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency. Abstract of the “HTLV European Research Network (HERN) (4-6 June, 2004: Halkidiki, Grèce)
  3. 47. Marban, C., Redel, L., Suzanne, S., Lecestre, D., Dequiedt, F., Van Lint, C., Aunis, D., & Rohr, O. (2004). Inhibition of HIV-1 expression by CTIP2-mediated recruitment of HDAC activities to the Long Terminal Repeat. Abstract of 2004 Keystone Symposium “Chromatin Structure and Function" (4-6 June, 2004: Cancun, Mexico)
  4. 48. Demonte, D., Quivy, V., Vanhulle, C., Moutschen, M., Vaira, D., Hermans, P., De Wit, S., Burny, A., Piette, J., & Van Lint, C. (2004). Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies. Abstract of the Meeting « Chromatin structure and gene expression mechanisms as therapeutic targets» (28-31 Jan, 2004: European Conference Center Kirchberg-Luxembourg)
  5. 49. Dekoninck, A., Calomme, C., Nizet, S., De Launoit, Y., Burny, A., Ghysdael, J., & Van Lint, C. (2004). Role of the transcription factor PU.1 and role of chromatin organization in the transcriptional regulation of the Bovine Leukemia Virus (BLV). Abstract of the Meeting « Chromatin structure and gene expression mechanisms as therapeutic targets» (28-31 Jan, 2004: European Conference Center Kirchberg-Luxembourg)
  6. 50. Quivy, V., Adam, E., Demonte, D., Bex, F., Collette, Y., Chariot, A., Vanhulle, C., Burny, A., Bours, V., Piette, J., & Van Lint, C. (2004). Potentiation of TNFalpha-induced NF-kappaB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearence of IkBalpha. Abstract of the Meeting « Chromatin structure and gene expression mechanisms as therapeutic targets» (28-31 Jan, 2004: European Conference Center Kirchberg-Luxembourg)
  7. 51. Calomme, C., Dekoninck, A., Nizet, S., Adam, E., Nguyen, T. L.-A., Van Den Broeke, A., Willems, L., Kettmann, R., Burny, A., & Van Lint, C. (2004). Overlapping CRE and E box motifs in the Enhancer Sequences of the Bovine Leukemia Virus 5’ Long Terminal Repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency. Abstract of the Meeting « Chromatin structure and gene expression mechanisms as therapeutic targets» (28-31 Jan, 2004: European Conference Center Kirchberg-Luxembourg)
  8. 52. Goffin, V., Demonte, D., Vanhulle, C., Collette, Y., Veithen-Fort, E., Burny, A., & Van Lint, C. (2003). Characterization of the transcriptional enhancer located in the pol gene of HIV-1. Abstract of the CSH Meeting on Mechanisms of Eukaryotic Transcription (27-31 Aug, 2003: Spring Harbor Laboratory, Cold Spring Harbor, New York, USA)
  9. 53. Nguyen, T. L.-A., Adam, E., Calomme, C., Nizet, S., Burny, A., De Launoit, Y., & Van Lint, C. (2003). Synergistic activation of the BLV promoter transcriptional activity by TaxBLV and inhibitors of deacetylases. Abstract of the CSH Meeting on Mechanisms of Eukaryotic Transcription (27-31 Aug, 2003: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA)
  10. 54. Dekoninck, A., Calomme, C., Nizet, S., De Launoit, Y., Burny, A., Ghysdael, J., & Van Lint, C. (2003). Identification and characterization of a PU.1/SPI-B binding site in the Bovine Leukemia Virus Long Terminal Repeat. Abstract of the CSH Meeting on Mechanisms of Eukaryotic Transcription (27-31 Aug, 2003: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA)
  11. 55. Quivy, V., Adam, E., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Schoonbroodt, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., De Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (2003). Potentiation of TNFalpha-induced NF-kappaB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearence of IkBalpha. Abstract of the CSH Meeting on Mechanisms of Eukaryotic Transcription (27-31 Aug, 2003: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA)
  12. 56. Collette, Y., Quivy, V., Adam, E., Vire, B., Demonte, D., Olive, D., Burny, A., & Van Lint, C. (2003). Deacetylase inhibitors as candidate drugs to purge latently HIV-1-infected reservoirs in HAART patients? Mechanistic insights into regulation of viral replication by Deacetylase inhibitors. Abstract of the 2nd IAS Conference on HIV Pathogenesis and Treatment (13-16 July, 2003)

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>